Poulton Jeffrey V.
- SEC CIK
- 0001782962
In the past year, 5 open-market sale filings worth $4.95M and no purchases.
Current role at each company
- CRVO CervoMed Inc.Directoras of Jun 10, 2026
- ALNY Alnylam Pharmaceuticals, Inc.EVP, Chief Financial Officeras of Mar 6, 2026
- QTTB Q32 Bio Inc.Directoras of Jun 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.95M
- 5 filings
- Net
- −$4.95M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Poulton Jeffrey V. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
EVP, Chief Financial Officer15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −2.47K | $323.08 | −$797.4K | −3.8%61.8K after | 8 lots |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −2.21K | $327.65 | −$722.8K | −3.3%64.3K after | 10 lots |
| Feb 17, 2026 (view filing) | Feb 13 | 4 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −2.24K | $310.08 | −$695.2K | −3.6%59.8K after | |
| Jan 14, 2026 (view filing) | Jan 12 | 2 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −2.78K | $362.87 | −$1.01M | −4.6%57.5K after | 21 lots |
| Oct 3, 2025 (view filing) | Oct 2 | 1 day | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −3.82K | $452.05 | −$1.73M | −6.6%54.1K after | 12 lots |
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −2.27K | $453.27 | −$1.03M | −4.3%50.1K after | 8 lots |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −1.26K | $243.78 | −$308.1K | −2.6%47.8K after | 7 lots |
| Mar 3, 2025 (view filing) | Feb 28 | 3 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −796 | $241.70 | −$192.4K | −2.3%33.9K after | 8 lots |
| Feb 18, 2025 (view filing) | Feb 14 | 4 days | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −967 | $255.17 | −$246.7K | −2.9%32.8K after | 12 lots |
| Nov 27, 2024 (view filing) | Nov 26 | 1 day | Poulton Jeffrey V.EVP, Chief Financial Officer | SSale | −1.68K | $250.98 | −$422.1K | −5.2%30.6K after | 5 lots |